Overview
- Ultrahuman and Click Therapeutics have partnered to develop Migraine PowerPlug, a software feature integrating wearable health insights with digital therapeutic technology.
- The platform aims to help users identify migraine-related patterns and receive personalized guidance around sleep, stress, activity, and hydration.
- Migraine PowerPlug is expected to launch through the Ultrahuman app in early 2026 across the U.S., Canada, EU, India, Australia, and other markets.
The News
Ultrahuman and Click Therapeutics have partnered to develop Migraine PowerPlug, a software-based feature within the Ultrahuman platform that combines wearable biomarker data with technology derived from Click’s FDA-authorized digital therapeutic CT-132. The platform is designed to help users track trends in sleep, recovery, stress, HRV, and activity while receiving personalized, evidence-based guidance to better understand and manage potential migraine triggers.
The collaboration aims to extend migraine support beyond clinical visits by translating daily physiological patterns into actionable interventions, including personalized goals for movement, sleep, and hydration. Migraine PowerPlug is scheduled to launch following a pilot phase in early 2026, with availability planned across multiple global markets.
Industry Perspective
With migraine affecting more than one billion people globally and disproportionately impacting women, digital health and wearable technologies are creating new opportunities for continuous, personalized support. Combining biometric monitoring with clinically validated digital interventions could help bridge the gap between episodic clinical care and the day-to-day management of chronic neurological conditions.
Strategic Impact
The partnership expands Ultrahuman’s health monitoring ecosystem into migraine support while enabling Click Therapeutics to extend its digital therapeutic technology into the growing wearable health market. By combining real-time biomarker insights with guided behavioral interventions, Migraine PowerPlug could establish a more personalized model for managing migraine risk and symptoms outside traditional healthcare settings.
Source: Click Therapeutics
